At Edinburgh Innovations we benefit society and the economy by helping researchers, students and industry drive innovation. We seek opportunities, we build partnerships, we make the journey easy, and we add value at every stage.
Edinburgh Innovations and the Covid-19 pandemic
Edinburgh Innovations is working hard to drive innovation that can help the national effort to tackle the Covid-19 pandemic and support the NHS. We are also endeavouring to leverage the University’s expertise to help businesses and public-sector bodies build resilience and ensure their longevity during and beyond the crisis.
L&G partnership to revolutionise care in later life
Legal & General, the UK’s largest pension fund investor, and the University of Edinburgh have agreed a major collaboration to improve understanding of care in later life and revolutionise how it is delivered. The agreement will establish the Advanced Care Research Centre (ACRC), a seven-year multi-disciplinary research programme that is the first of its kind in the UK. ACRC will combine research across fields including medicine and other care professions, life sciences, engineering, informatics, data and social sciences. Edinburgh Innovations led the industry engagement that resulted in the agreement, bringing together more than 50 academics from across the University to meet the identified need. ACRC will receive £20 million funding for research from Legal & General, marking the University’s largest industry investment of its kind and the largest to be confirmed as part of the Data-Driven Innovation initiative of the Edinburgh and South East Scotland City Region Deal. Read more on the L&G partnership or find out how you can work with the University of Edinburgh below.
MRC funds trial of novel treatment for advanced cancer symptoms
Researchers were awarded almost £1 million by the Medical Research Council for a clinical study of a novel approach to treating advanced cancer symptoms that could improve quality of life for patients. The Biomedical Catalyst grant awarded to the Institute of Genetics and Molecular Medicine at the University of Edinburgh will be supported by a collaboration with XBiotech, a global biosciences company based in Austin, Texas, which is supplying the treatment product, bermekimab. Edinburgh Innovations supported the University team in development of the project including liaising with XBiotech, project partners and the MRC to fund the study. Read more on the bermekimab trial or access our services for staff.
Graduates’ consultancy helps businesses tackle tech ethics
Two philosophy masters graduates are the founders of a consultancy to help businesses navigate the growing ethical challenges of using artificial intelligence and other burgeoning technology. Ethical Intelligence, launched by Olivia Gamelin and Anna van Oosterzee, has assembled a team of 15 ethics experts and has provided services for the Scottish Government, global investment firm Franklin Templeton and the University of Edinburgh. Edinburgh Innovations helped the pair connect with essential advisers including lawyers and accountants and helped them access funding. We also hosted and supported them through our 12-week Summer Startup Accelerator programme. Read more about Ethical Intelligence or access our services for students.